Skip to Content

Olodaterol Dosage

Medically reviewed on December 26, 2017.

Applies to the following strengths: 2.5 mcg/inh

Usual Adult Dose for Chronic Obstructive Pulmonary Disease

-5 mcg (2 inhalations) orally once a day

Use: Maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

Mild to moderate liver dysfunction: No adjustment recommended.
Severe liver dysfunction: Data not available


-Long-acting beta2-adrenergic agonists (LABA) increase the risk of asthma-related death.
-A placebo-controlled study with another long-acting beta2-adrenergic agonist (salmeterol) showed an increase in asthma-related deaths in patients receiving salmeterol.
-This finding with salmeterol is considered a class effect of LABA, including this drug.
-The safety and efficacy of this drug in patients with asthma have not been established. This drug is not indicated for the treatment of asthma.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
-Administer at the same time of the day.
-The recommended daily dose should not be exceeded.
-This drug is for oral inhalation only.
-To ensure proper use of the inhalation device, see Instructions for its use.

-This drug is not indicated to treat asthma or acute deterioration of COPD.

Patient advice:
-Notify the physician immediately if experiencing any of the following: Worsening of symptoms; decreasing effectiveness of inhaled, short-acting beta2-agonists; need for more inhalations than usual of the inhaled, short-acting beta2-agonists; significant decrease in lung function as outlined by the physician.
-Therapy with this drug should not be stopped without physician/provider guidance since symptoms may recur after discontinuation.
-Discontinue previous regular use of short acting beta2-agonist and use them only for the symptomatic relief of acute symptoms.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.